Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTO1 | P78417 | 2/20 | 0.80 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.80 |
| ▸ | MEN1 | O00255 | 2/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.72 |
| ▸ | PDE4A | P27815 | 1/20 | 0.72 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.72 |
| ▸ | PSEN1 | P49768 | 4/20 | 0.65 |
| ▸ | TTPA | P49638 | 3/20 | 0.60 |
| ▸ | LMNA | P02545 | 3/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.60 |
| ▸ | USP2 | O75604 | 1/20 | 0.60 |
| ▸ | THRB | P10828 | 1/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | NR1I2 | O75469 | 3/20 | 0.54 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.53 |
| ▸ | PGR | P06401 | 1/20 | 0.51 |
| ▸ | AKT1 | P31749 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16075621 | 1.00 | GSTO1 (0.80) | GSTO1PTPN1MEN1KMT2APDE4A | |
| SCHEMBL29358491 | 1.00 | GSTO1 (0.80) | GSTO1PTPN1MEN1KMT2APDE4A | |
| SCHEMBL12939323 | 1.00 | GSTO1 (0.80) | GSTO1PTPN1MEN1KMT2APDE4A | |
| SCHEMBL12535813 | 0.97 | GSTO1 (0.75) | GSTO1PTPN1MEN1KMT2APDE4A | |
| SCHEMBL19725725 | 0.96 | GSTO1 (0.74) | GSTO1PTPN1MEN1KMT2APDE4A | |
| SCHEMBL16075620 | 0.95 | GSTO1 (0.84) | GSTO1PTPN1MEN1KMT2APDE4A | |
| SCHEMBL19194502 | 0.95 | GSTO1 (0.75) | GSTO1PTPN1MEN1KMT2APDE4A | |
| SCHEMBL29642083 | 0.95 | GSTO1 (0.75) | GSTO1PTPN1MEN1KMT2APDE4A | |
| SCHEMBL4619077 | 0.93 | GSTO1 (0.93) | GSTO1PTPN1MEN1KMT2APDE4A | |
| SCHEMBL17749237 | 0.93 | GSTO1 (0.93) | GSTO1PTPN1MEN1KMT2APDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 10256 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144812-A1 | ANTIOXIDANT OPHTHALMIC EMULSION | ALCON INC. (CH) | 2026-05-28 | — | — | US | claimed |
| US-12636251-B1 | Glycoside-containing aqueous formulations having a lipophilic active component | Doane Technology Group LLC (US) | 2026-05-26 | — | — | US | claimed |
| CN-122075463-A | Pharmaceutical composition containing melagatran besylate and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122075397-A | In-situ foam gel containing exosomes and preparation method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| WO-2026104851-A1 | PHARMACEUTICAL COMPOSITIONS | Apollo AP10 Limited (GB) | 2026-05-21 | — | — | WO | claimed |
| US-20260137626-A1 | Pharmaceutical Formulation | CIPLA LTD (IN) | 2026-05-21 | — | — | US | claimed |
| US-20260137635-A1 | NOVEL FORMULATIONS OF EPINEPHRINE AND USES THEREOF | NANJING HAIWEI PHARMACEUTICAL TECH CO LTD (CN) | 2026-05-21 | — | — | US | claimed |
| EP-4744660-A1 | GLP-1R AGONIST PREPARATION AND PREPARATION METHOD THEREFOR | ASCLETIS PHARMA (CHINA) CO., LIMITED (HK) | 2026-05-20 | — | — | EP | claimed |
| CN-122058619-A | High-barrier antibacterial CPP composite film and preparation method thereof | 周口鑫塑实业有限责任公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122037607-A | Thiophenol-heptamethine cyanine dye derivative, self-assembled nanoparticle thereof, preparation method and application | 温州医科大学附属第二医院（温州医科大学附属育英儿童医院） | 2026-05-15 | — | — | CN | claimed |
| CN-112190542-B | Aqueous in-situ gel ophthalmic preparation for treating xerophthalmia | 艾威药业(珠海)有限公司 | 2022-01-28 | — | — | CN | claimed |
| US-20220023266-A1 | CRF1 RECEPTOR ANTAGONIST, PHARMACEUTICAL FORMULATIONS AND SOLID FORMS THEREOF FOR THE TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA | SANOFI (FR) | 2022-01-27 | — | — | US | claimed |
| EP-3943070-A1 | LONG-ACTING FORMULATIONS OF BEDAQUILINE | Janssen Pharmaceutica NV (BE) | 2022-01-26 | — | — | EP | claimed |
| EP-3943071-A1 | COMPOSITION COMPRISING NATURAL LIPOPHILIC COMPOUNDS, USE OF THE COMPOSITION AND METHOD FOR PREPARING THE COMPOSITION | Khinikadze, Zurab Durmischchanowitch (RU) | 2022-01-26 | — | — | EP | claimed |
| CN-113967196-A | Metronidazole microcapsule tablet and preparation method thereof | 瑞普（天津）生物药业有限公司 | 2022-01-25 | — | — | CN | claimed |
| US-11229230-B2 | Antioxidant-enriched multivitamin composition and methods of use | CALLION PHARMA, LLC (US) | 2022-01-25 | — | — | US | claimed |
| CN-113952298-A | Cefquinome sulfate nano suspension and preparation method thereof | 江苏农牧科技职业学院 | 2022-01-21 | — | — | CN | claimed |
| CN-113956259-A | Preparation method of acrylamide medicine | 华北水利水电大学 | 2022-01-21 | — | — | CN | claimed |
| CN-113952303-A | Preparation composition containing ginsenoside CK and preparation method thereof | 石家庄以岭药业股份有限公司 | 2022-01-21 | — | — | CN | claimed |
| CN-113966213-A | Self-emulsifying drug delivery system for delivery of lipophilic compounds | 耶路撒冷希伯来大学伊森姆研究发展有限公司 | 2022-01-21 | — | — | CN | claimed |